E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/29/2022 in the Prospect News Convertibles Daily.

Convertibles Calendar: Cytokinetics on Thursday

June 30

CYTOKINETICS INC.:

• $450 million five-year convertible notes

• $90 million greenshoe

• Coupon of 3% to 3.5% and an initial conversion premium of 30% to 35%

• Non-callable until July 6, 2025 and then are subject to a 130% hurdle

• Rule 144A

• Cantor Fitzgerald & Co.

• Repurchase a portion of the company’s 4% convertible notes due 2026 in privately negotiated transactions and support the clinical development and commercial launch of products in its pipeline

• South San Francisco, Calif.-based biopharmaceutical company


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.